Breaking News Instant updates and real-time market news.

09:15
04/17/20
04/17
09:15
04/17/20
09:15

Cowen airfreight analyst to hold an analyst/industry conference call

Airfreight & Aircraft Leasing Analyst Becker, along with Professor David Yu, Chairman of China Aviation Valuation Advisors, discusses the industry on an Analyst/Industry conference call to be held on April 17 at 10 am.

TODAY'S FREE FLY STORIES

Recommendations
Cinemark price target lowered to $24 from $26 at Imperial Capital » 04:53
05/26/20
05/26
04:53
05/26/20
04:53
CNK

Cinemark

$14.05 /

-0.2 (-1.40%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNK Cinemark
$14.05 /

-0.2 (-1.40%)

CNK Cinemark
$14.05 /

-0.2 (-1.40%)

05/18/20
Fly Intel: Top five analyst downgrades
05/18/20 B. Riley FBR
B. Riley FBR downgrades Cinemark on second half recovery concerns
05/18/20 B. Riley FBR
Cinemark downgraded to Neutral from Buy at B. Riley FBR
04/23/20 Macquarie
Cinemark upgraded to Outperform from Neutral at Macquarie
CNK Cinemark
$14.05 /

-0.2 (-1.40%)

CNK Cinemark
$14.05 /

-0.2 (-1.40%)

CNK Cinemark
$14.05 /

-0.2 (-1.40%)

CNK Cinemark
$14.05 /

-0.2 (-1.40%)

Initiation
Pegasystems initiated with a Buy at Goldman Sachs » 04:51
05/26/20
05/26
04:51
05/26/20
04:51
PEGA

Pegasystems

$91.96 /

+2.035 (+2.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEGA Pegasystems
$91.96 /

+2.035 (+2.26%)

PEGA Pegasystems
$91.96 /

+2.035 (+2.26%)

04/30/20 Wedbush
Pegasystems price target raised to $104 from $96 at Wedbush
04/30/20 KeyBanc
Pegasystems price target lowered to $104 from $110 at KeyBanc
04/22/20 Wedbush
Pegasystems price target lowered to $96 from $103 at Wedbush
04/14/20 Sidoti
Pegasystems initiated with a Buy at Sidoti
PEGA Pegasystems
$91.96 /

+2.035 (+2.26%)

Upgrade
Take-Two upgraded to Outperform from Market Perform at BMO Capital » 04:48
05/26/20
05/26
04:48
05/26/20
04:48
TTWO

Take-Two

$140.51 /

+2.13 (+1.54%)

BMO Capital analyst…

BMO Capital analyst Gerrick Johnson upgraded Take-Two Interactive to Outperform from Market Perform with a price target of $170, up from $120. The stock closed Friday up $2.32 to $140.51. Stay at home tailwinds should persist for the video game industry, which is defensive in times of economic uncertainty, Johnson tells investors in a research note. Further, Take-Two's performance in Q4 illustrates the strength of its core franchises during this time of uncertainty, adds the analyst. Johnson is encouraged by the company's "strategy to seize opportunities" in new platforms, distribution models, and game genres, which he believes should provide more "stable, growing earnings and cash flow over time."

ShowHide Related Items >><<
TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

05/21/20 BofA
BofA downgrades Take-Two to Neutral, sees 'superior upside potential' elsewhere
05/21/20 BofA
Take-Two downgraded to Neutral from Buy at BofA
05/21/20 Wedbush
Take-Two price target raised to $170 from $131 at Wedbush
05/21/20 MKM Partners
Take-Two price target raised to $145 from $124 at MKM Partners
TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

TTWO Take-Two
$140.51 /

+2.13 (+1.54%)

Upgrade
Regeneron upgraded to Overweight from Equal Weight at Wells Fargo » 04:44
05/26/20
05/26
04:44
05/26/20
04:44
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Downgrade
Scotts Miracle-Gro downgraded to Market Perform from Strong Buy at Raymond James » 04:43
05/26/20
05/26
04:43
05/26/20
04:43
SMG

Scotts Miracle-Gro

$150.68 /

+1 (+0.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMG Scotts Miracle-Gro
$150.68 /

+1 (+0.67%)

SMG Scotts Miracle-Gro
$150.68 /

+1 (+0.67%)

05/14/20 SunTrust
Scotts Miracle-Gro, Central Garden & Pet price targets raised at SunTrust
05/07/20 SunTrust
Scotts Miracle-Gro price target raised to $140 from $115 at SunTrust
03/30/20 BofA
US 1 List changes at BofA
03/27/20 SunTrust
Scotts Miracle-Gro price target raised to $115 from $100 at SunTrust
SMG Scotts Miracle-Gro
$150.68 /

+1 (+0.67%)

Upgrade
iRobot upgraded to Neutral from Underweight at JPMorgan » 04:42
05/26/20
05/26
04:42
05/26/20
04:42
IRBT

iRobot

$73.14 /

+0.63 (+0.87%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRBT iRobot
$73.14 /

+0.63 (+0.87%)

IRBT iRobot
$73.14 /

+0.63 (+0.87%)

05/18/20 Dougherty
Dougherty upgrades iRobot to Buy amid fall in house cleaning services
05/18/20 Dougherty
iRobot upgraded to Buy from Neutral at Dougherty
04/29/20 Piper Sandler
iRobot price target raised to $50 from $41 at Piper Sandler
04/22/20 JPMorgan
JPMorgan downgrades iRobot to Underweight on unfavorable risk/reward
IRBT iRobot
$73.14 /

+0.63 (+0.87%)

IRBT iRobot
$73.14 /

+0.63 (+0.87%)

IRBT iRobot
$73.14 /

+0.63 (+0.87%)

IRBT iRobot
$73.14 /

+0.63 (+0.87%)

Upgrade
HP Enterprise upgraded to Neutral from Underweight at JPMorgan » 04:41
05/26/20
05/26
04:41
05/26/20
04:41
HPE

HP Enterprise

$9.17 /

-1.18 (-11.40%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Raymond James
HP Enterprise downgraded to Market Perform from Outperform at Raymond James
05/22/20 Morgan Stanley
Second quarter 'not yet a bottom' for HP Enterprise, says Morgan Stanley
05/22/20 Citi
HP Enterprise earnings call leaves more questions than answers, says Citi
HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

HPE HP Enterprise
$9.17 /

-1.18 (-11.40%)

Upgrade
LyondellBasell upgraded to Buy from Hold at Deutsche Bank » 04:37
05/26/20
05/26
04:37
05/26/20
04:37
LYB

LyondellBasell

$60.42 /

+0.17 (+0.28%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYB LyondellBasell
$60.42 /

+0.17 (+0.28%)

LYB LyondellBasell
$60.42 /

+0.17 (+0.28%)

05/11/20 Alembic Global
LyondellBasell downgraded to Neutral from Overweight at Alembic Global
05/04/20
Fly Intel: Top five analyst downgrades
05/04/20 BofA
LyondellBasell downgraded to Underperform from Neutral at BofA
05/04/20 BofA
Dow Inc. downgraded to Underperform from Buy at BofA
LYB LyondellBasell
$60.42 /

+0.17 (+0.28%)

LYB LyondellBasell
$60.42 /

+0.17 (+0.28%)

LYB LyondellBasell
$60.42 /

+0.17 (+0.28%)

General news
FX Action: USD-CAD dropped to a five-day low » 03:55
05/26/20
05/26
03:55
05/26/20
03:55

FX Action: USD-CAD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: The dollar and yen have weakened » 03:25
05/26/20
05/26
03:25
05/26/20
03:25

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Kuroda said BoJ will do whatever it can » 02:00
05/26/20
05/26
02:00
05/26/20
02:00

Kuroda said BoJ will do…

Kuroda said BoJ will do whatever it can, but warned the central bank may not be able to keep interest rates low without trust in Japan's finances over the long term. Kuroda told lawmakers that the BoJ will buy T-bills and government bonds actively and consider changing rates for its yield curve control if necessary. The BoJ would also consider expanding its special lending programs to further support firms if needed. Monetary easing should be continued until the BoJ's price target is met, while extraordinary measures in response to the pandemic will fade out post-virus.

General news
Asian Market Update: » 01:45
05/26/20
05/26
01:45
05/26/20
01:45

Asian Market Update: The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Cognex initiated with a Hold at HSBC » 20:29
05/25/20
05/25
20:29
05/25/20
20:29
CGNX

Cognex

$61.69 /

+0.54 (+0.88%)

HSBC initiated coverage…

HSBC initiated coverage of Cognex with a Hold rating and $55 price target.

ShowHide Related Items >><<
CGNX Cognex
$61.69 /

+0.54 (+0.88%)

CGNX Cognex
$61.69 /

+0.54 (+0.88%)

04/28/20 Raymond James
Cognex price target raised to $60 from $48 at Raymond James
03/23/20 Morgan Stanley
Morgan Stanley cuts Multi-Industry estimates, shakes up ratings with 7 changes
03/23/20 Morgan Stanley
Cognex downgraded to Underweight from Equal Weight at Morgan Stanley
12/12/19 UBS
Cognex initiated with a Neutral at UBS
CGNX Cognex
$61.69 /

+0.54 (+0.88%)

CGNX Cognex
$61.69 /

+0.54 (+0.88%)

Upgrade
RWE AG upgraded to Conviction Buy from Buy at Goldman Sachs » 20:28
05/25/20
05/25
20:28
05/25/20
20:28
RWEOY

RWE AG

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Alberto Gandolfi added RWE AG to the firm's Conviction List with a price target of EUR 37, up from EUR 33.50. The analyst keeps a Buy rating on the shares. Ring-fencing the company's lignite activities activities would leave RWE a near-pure play on renewables, Gandolfi tells investors in a research note. The analyst sees 30% upside in a sum-of-the-parts based valuation after analyzing the next phase in RWE's transformation.

ShowHide Related Items >><<
RWEOY RWE AG
$0.00 /

+ (+0.00%)

05/15/20 Barclays
RWE AG price target raised to EUR 33 from EUR 32 at Barclays
05/15/20 Morgan Stanley
RWE AG price target raised to EUR 36 from EUR 35 at Morgan Stanley
05/06/20 Credit Suisse
RWE AG upgraded to Outperform from Neutral at Credit Suisse
05/05/20 Barclays
RWE AG price target raised to EUR 32 from EUR 31 at Barclays
Upgrade
Iberdrola upgraded to Buy from Neutral at Goldman Sachs » 20:24
05/25/20
05/25
20:24
05/25/20
20:24
IBDRY

Iberdrola

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Alberto Gandolfi upgraded Iberdrola to Buy from Neutral with a price target of EUR 10, up from EUR 9.75. Although the recent drop in power prices and the deprecation of key currencies will limit earnings growth to 2023, the company's portfolio by then should be 90% composed of fully regulated networks, renewables and contracted generation, which offer high quality earnings, Gandolfi tells investors in a research note. As such, the analyst expects Iberdrola to close the valuation gap to its fully regulated peers.

ShowHide Related Items >><<
IBDRY Iberdrola
$0.00 /

+ (+0.00%)

IBDRY Iberdrola
$0.00 /

+ (+0.00%)

04/09/20 Oddo BHF
Iberdrola upgraded to Buy from Neutral at Oddo BHF
04/07/20 RBC Capital
Iberdrola downgraded to Sector Perform from Outperform at RBC Capital
04/07/20 UBS
National Grid, Iberdrola upgraded to Buy; Centrica, Engie cut to Neutral at UBS
04/07/20 UBS
Iberdrola upgraded to Buy from Neutral at UBS
Downgrade
Ascential downgraded to Neutral from Buy at Goldman Sachs » 20:21
05/25/20
05/25
20:21
05/25/20
20:21
AIAPF

Ascential

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Katherine Tait downgraded Ascential to Neutral from Buy with an unchanged price target of 289 GBp. The analyst sees only 7% upside in the shares following 22% rally over the past month. Ascential is building a valuable set of e-commerce analytics tools which should drive future organic revenue growth, but it faces nearer-term risks across exhibitions and MediaLink, Tait tells investors in a research note.

ShowHide Related Items >><<
AIAPF Ascential
$0.00 /

+ (+0.00%)

AIAPF Ascential
$0.00 /

+ (+0.00%)

04/06/20 Morgan Stanley
Ascential downgraded to Equal Weight from Overweight at Morgan Stanley
03/19/20 HSBC
Ascential downgraded to Hold from Buy at HSBC
03/17/20 Goldman Sachs
Ascential downgraded to Buy from Conviction Buy at Goldman Sachs
Hot Stocks
Fly Intel: Top five weekend stock stories » 19:58
05/25/20
05/25
19:58
05/25/20
19:58
HTZ

Hertz

$2.84 /

-0.215 (-7.04%)

, REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

, AMZN

Amazon.com

$2,435.90 /

-11.65 (-0.48%)

, WMT

Walmart

$124.32 /

-0.64 (-0.51%)

, NVAX

Novavax

$46.14 /

-3.975 (-7.93%)

, WGO

Winnebago

$58.06 /

+0.47 (+0.82%)

, POOL

Pool Corp.

$238.08 /

-0.32 (-0.13%)

, YETI

Yeti

$30.41 /

+0.38 (+1.27%)

, DBX

Dropbox

$21.67 /

-0.465 (-2.10%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Hertz Global (HTZ) has announced that it and certain of its U.S. and Canadian subsidiaries have filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. "The impact of COVID-19 on travel demand was sudden and dramatic, causing an abrupt decline in the Company's revenue and future bookings. Hertz took immediate actions to prioritize the health and safety of employees and customers, eliminate all non-essential spending and preserve liquidity. However, uncertainty remains as to when revenue will return and when the used-car market will fully re-open for sales, which necessitated today's action. The financial reorganization will provide Hertz a path toward a more robust financial structure that best positions the Company for the future as it navigates what could be a prolonged travel and overall global economic recovery," the company said in a statement. Hertz's principal international operating regions including Europe, Australia and New Zealand are not included in the U.S. Chapter 11 proceedings. In addition, Hertz's franchised locations, which are not owned by the company, also are not included in the Chapter 11 proceedings. 2. Regeneron Pharmaceuticals (REGN) announced the commencement of an underwritten public secondary offering of its common stock through which Sanofi (SNY) intends to exit its investment in Regeneron shares. The shares being offered by Sanofi will be sold in an underwritten public offering. Sanofi currently owns approximately 23.2M Regeneron shares and intends to sell approximately 12.8M shares in the public offering. Sanofi also expects to grant the underwriters a 30-day option to purchase an additional 10% of the shares offered in the base offering. The registered offering and share repurchase will have no impact on the ongoing collaboration between Regeneron and Sanofi. Regeneron also announced that subject to and immediately following the close of the secondary offering, Regeneron agreed to repurchase approximately $5B of common stock directly from Sanofi. The purchase price to be paid by Regeneron will be equal to the net offering price per share after deducting any underwriters' discount and commission. Following the offering and Regeneron's $5B share repurchase, and assuming that the underwriters exercise their option to purchase additional shares in full, Sanofi will have disposed of all of its shares, other than 400,000 shares it intends to retain. 3. The impact of COVID-19 hasn't been evenly felt among the nation's retailers, with the biggest and strongest not just surviving, but thriving, while many smaller store chains and mom-and-pop shops face disaster, Teresa Rivas wrote in this week's edition of Barron's. In the past five years, the rise of e-commerce has changed the retail industry, tilting the landscape in favor of behemoths such as Amazon (AMZN) and Walmart (WMT) that can afford slick websites and fast, free delivery service, the author noted. Now, without a vaccine or effective treatment for coronavirus available near-term, these well-capitalized companies are likely to keep gobbling up market share at the expense of smaller operators, Rivas contended. 4. Novavax (NVAX) announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology. NVX-CoV2373 includes Novavax' proprietary Matrix-M adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies. Preliminary immunogenicity and safety results from the Phase 1 portion of the trial are expected in July 2020. The Phase 1/2 clinical trial is being conducted in two parts. The Phase 1 portion is a randomized, observer-blinded, placebo-controlled trial designed to evaluate the immunogenicity and safety of NVX-CoV2373, both adjuvanted with Matrix-M and unadjuvanted. The trial is enrolling approximately 130 healthy participants 18 to 59 years of age at two sites in Australia. The protocol's two-dose trial regimen assesses two dose sizes with Matrix-M and without. The Phase 2 portion is expected to be conducted in multiple countries, including the United States, and would assess immunity, safety and COVID-19 disease reduction in a broader age range. This Phase 1/2 approach allows for rapid advancement of NVX-CoV2373 during the pandemic. The trial is being supported by the recently announced funding arrangement with the Coalition for Epidemic Preparedness Innovations. 5. Winnebago Industries (WGO), Pool Cor. (POOL), Yeti (YETI) and DropBox (DBX) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
YETI Yeti
$30.41 /

+0.38 (+1.27%)

WMT Walmart
$124.32 /

-0.64 (-0.51%)

WGO Winnebago
$58.06 /

+0.47 (+0.82%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

POOL Pool Corp.
$238.08 /

-0.32 (-0.13%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

DBX Dropbox
$21.67 /

-0.465 (-2.10%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/12/20 Barrington
Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
05/11/20 B. Riley FBR
Amazon buyout may not appeal to AMC shareholders, says B. Riley FBR
WMT Walmart
$124.32 /

-0.64 (-0.51%)

05/21/20 Bernstein
Walmart built for crisis, investing despite uncertainty, says Bernstein
05/20/20 Credit Suisse
Walmart price target raised to $135 from $127 at Credit Suisse
05/20/20 Guggenheim
Walmart price target raised to $140 from $135 at Guggenheim
05/20/20 Deutsche Bank
Walmart price target raised to $139 from $134 at Deutsche Bank
NVAX Novavax
$46.14 /

-3.975 (-7.93%)

05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
WGO Winnebago
$58.06 /

+0.47 (+0.82%)

05/12/20 SunTrust
Winnebago price target raised to $60 from $45 at SunTrust
04/17/20 Wolfe Research
Winnebago initiated with a Peer Perform at Wolfe Research
03/26/20 SunTrust
Winnebago price target raised to $38 from $28 at SunTrust
01/27/20 KeyBanc
Winnebago initiated with an Overweight at KeyBanc
POOL Pool Corp.
$238.08 /

-0.32 (-0.13%)

05/19/20 KeyBanc
Pool Corp. price target raised to $250 from $225 at KeyBanc
05/19/20 KeyBanc
Pool Corp. price target raised to $250 from $225 at KeyBanc
05/18/20 William Blair
Pool Corp. remains 'favorite safety stock' at William Blair
04/17/20 Sidoti
Pool Corp. downgraded to Neutral from Buy at Sidoti
YETI Yeti
$30.41 /

+0.38 (+1.27%)

05/05/20 Piper Sandler
Yeti price target lowered to $34 from $50 at Piper Sandler
04/28/20 BTIG
Yeti initiated with a Buy at BTIG
04/17/20 Stifel
Yeti downgraded to Hold from Buy at Stifel
04/15/20
Fly Intel: Top five analyst downgrades
DBX Dropbox
$21.67 /

-0.465 (-2.10%)

05/15/20 Gordon Haskett
Gordon Haskett points to possible signs of activism at Dropbox, McKesson
05/15/20 Citi
Dropbox initiated with a Buy at Citi
05/08/20 Jefferies
Dropbox price target raised to $22 from $20 at Jefferies
03/26/20 Goldman Sachs
Dropbox downgraded to Sell from Neutral at Goldman Sachs
YETI Yeti
$30.41 /

+0.38 (+1.27%)

WMT Walmart
$124.32 /

-0.64 (-0.51%)

WGO Winnebago
$58.06 /

+0.47 (+0.82%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

POOL Pool Corp.
$238.08 /

-0.32 (-0.13%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

DBX Dropbox
$21.67 /

-0.465 (-2.10%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

YETI Yeti
$30.41 /

+0.38 (+1.27%)

WMT Walmart
$124.32 /

-0.64 (-0.51%)

WGO Winnebago
$58.06 /

+0.47 (+0.82%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

DBX Dropbox
$21.67 /

-0.465 (-2.10%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

YETI Yeti
$30.41 /

+0.38 (+1.27%)

WMT Walmart
$124.32 /

-0.64 (-0.51%)

WGO Winnebago
$58.06 /

+0.47 (+0.82%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

DBX Dropbox
$21.67 /

-0.465 (-2.10%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

YETI Yeti
$30.41 /

+0.38 (+1.27%)

WMT Walmart
$124.32 /

-0.64 (-0.51%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

DBX Dropbox
$21.67 /

-0.465 (-2.10%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

AMZN Amazon.com
$2,435.90 /

-11.65 (-0.48%)

Upgrade
Emerald Holding upgraded to Buy from Neutral at Goldman Sachs » 19:46
05/25/20
05/25
19:46
05/25/20
19:46
EEX

Emerald Holding

$2.00 /

+0.09 (+4.71%)

Goldman Sachs analyst…

Goldman Sachs analyst Katherine Tait upgraded Emerald Holding to Buy from Neutral with a price target of $2.83, up from $2.78. The analyst notes that Emerald Holding confirmed on May 19 that its initial insurance claims related to shows cancelled owing to COVID-19 had been approved, removing a "significant overhang" from the stock related to uncertainty of insurance payments and therefore the company's liquidity position. Tait sees Emerald's current valuation as attractive.

ShowHide Related Items >><<
EEX Emerald Holding
$2.00 /

+0.09 (+4.71%)

EEX Emerald Holding
$2.00 /

+0.09 (+4.71%)

03/19/20 Barclays
Emerald Holding downgraded to Equal Weight from Overweight at Barclays
03/17/20
Fly Intel: Top five analyst downgrades
03/17/20 Goldman Sachs
Emerald Holding downgraded to Neutral from Buy at Goldman Sachs
08/21/19
Fly Intel: Top five analyst upgrades
EEX Emerald Holding
$2.00 /

+0.09 (+4.71%)

Initiation
Gamida Cell initiated with an Overweight at Piper Sandler » 18:25
05/25/20
05/25
18:25
05/25/20
18:25
GMDA

Gamida Cell

$5.25 /

+0.39 (+8.02%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff initiated coverage of Gamida Cell with an Overweight rating and $13 price target. The analyst notes that Gamida Cell recently reported positive Phase III data on omidubicel for patients receiving hematopoietic stem cell transplant showing 10 days faster neutrophil engraftment than standard umbilical cord blood transplant. Gamida Cell plans to report full Phase III data and file a BLA later this year, he adds. Tenthoff expects FDA approval next year with U.S. sales reaching $468M by 2028. Gamida Cell recently issued 15.3M shares at $4.50 raising gross proceeds of $69M, bringing pro forma cash to about $105M, the analyst points out.

ShowHide Related Items >><<
GMDA Gamida Cell
$5.25 /

+0.39 (+8.02%)

GMDA Gamida Cell
$5.25 /

+0.39 (+8.02%)

05/12/20 Oppenheimer
Gamida's omidubicel results 'potentially paradigm-changing,' says Oppenheimer
05/12/20 Oppenheimer
Gamida Cell price target raised to $20 from $18 at Oppenheimer
04/27/20
Fly Intel: Top five analyst initiations
04/27/20 H.C. Wainwright
Gamida Cell initiated with a Buy at H.C. Wainwright
GMDA Gamida Cell
$5.25 /

+0.39 (+8.02%)

GMDA Gamida Cell
$5.25 /

+0.39 (+8.02%)

Periodicals
NIH says Gilead drug works best in COVID patients on oxygen, Reuters reports » 18:21
05/25/20
05/25
18:21
05/25/20
18:21
GILD

Gilead

$73.31 /

-0.17 (-0.23%)

The U.S. National…

The U.S. National Institutes of Health said that data from its trial of Gilead Sciences' remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation, Reuters' Deena Beasley reports. The peer-reviewed data was published in the New England Journal of Medicine. Reference Link

ShowHide Related Items >><<
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/21/20 JPMorgan
Gilead Phase 3 ulcerative colitis study 'mixed at best,' says JPMorgan
05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

Periodicals
U.S. accuses China of blocking flights, demands action, Reuters reports » 18:19
05/25/20
05/25
18:19
05/25/20
18:19
ALK

Alaska Air

$31.03 /

-0.79 (-2.48%)

, LUV

Southwest

$28.88 /

-0.71 (-2.40%)

, DAL

Delta Air Lines

$22.68 /

-0.47 (-2.03%)

, JBLU

JetBlue

$9.24 /

-0.2 (-2.12%)

, UAL

United Airlines

$25.40 /

-0.45 (-1.74%)

, SAVE

Spirit Airlines

$10.17 /

+0.09 (+0.89%)

, AAL

American Airlines

$9.70 /

-0.175 (-1.77%)

The U.S. government has…

The U.S. government has accused the Chinese government of making it impossible for U.S. airlines to resume service to China and ordered four Chinese air carriers to file flight schedules with the U.S. government, Reuters' David Shepardson reports. The administration of President Donald Trump stopped short of imposing restrictions on Chinese air carriers but said talks with China had failed to produce an agreement, the author notes. Publicly traded companies in the space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL).Reference Link

ShowHide Related Items >><<
UAL United Airlines
$25.40 /

-0.45 (-1.74%)

SAVE Spirit Airlines
$10.17 /

+0.09 (+0.89%)

LUV Southwest
$28.88 /

-0.71 (-2.40%)

JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

AAL American Airlines
$9.70 /

-0.175 (-1.77%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Alaska Air price target lowered to $35 from $44 at Barclays
04/21/20 Deutsche Bank
Alaska Air price target lowered to $45 from $52 at Deutsche Bank
04/12/20
Airlines want Treasury to scrap proposal to make grant repayable, Reuters says
LUV Southwest
$28.88 /

-0.71 (-2.40%)

05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
05/04/20 Barclays
Southwest price target lowered to $35 from $40 at Barclays
04/30/20
Fly Intel: Top five analyst upgrades
DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
04/21/20 Deutsche Bank
Delta Air Lines price target lowered to $47 from $51 at Deutsche Bank
JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

05/04/20 Barclays
JetBlue price target lowered to $11 from $16 at Barclays
04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 Susquehanna
JetBlue downgraded to Neutral at Susquehanna
UAL United Airlines
$25.40 /

-0.45 (-1.74%)

05/04/20 Barclays
United Airlines price target lowered to $40 from $60 at Barclays
04/23/20 Citi
Citi cuts United Airlines target, opens 'negative 30-day catalyst watch'
SAVE Spirit Airlines
$10.17 /

+0.09 (+0.89%)

05/18/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
05/13/20 Citi
Citi opens positive '90-day catalyst watch' on Spirit despite target cut
AAL American Airlines
$9.70 /

-0.175 (-1.77%)

05/04/20 Barclays
American Airlines downgraded to Underweight from Equal Weight at Barclays
05/01/20 Evercore ISI
American Airlines price target lowered to $1 from $10 at Evercore ISI
04/27/20 Citi
American Airlines price target lowered to $10 from $13 at Citi
UAL United Airlines
$25.40 /

-0.45 (-1.74%)

SAVE Spirit Airlines
$10.17 /

+0.09 (+0.89%)

LUV Southwest
$28.88 /

-0.71 (-2.40%)

JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

AAL American Airlines
$9.70 /

-0.175 (-1.77%)

UAL United Airlines
$25.40 /

-0.45 (-1.74%)

LUV Southwest
$28.88 /

-0.71 (-2.40%)

JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

AAL American Airlines
$9.70 /

-0.175 (-1.77%)

UAL United Airlines
$25.40 /

-0.45 (-1.74%)

SAVE Spirit Airlines
$10.17 /

+0.09 (+0.89%)

LUV Southwest
$28.88 /

-0.71 (-2.40%)

JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

AAL American Airlines
$9.70 /

-0.175 (-1.77%)

UAL United Airlines
$25.40 /

-0.45 (-1.74%)

SAVE Spirit Airlines
$10.17 /

+0.09 (+0.89%)

LUV Southwest
$28.88 /

-0.71 (-2.40%)

JBLU JetBlue
$9.24 /

-0.2 (-2.12%)

DAL Delta Air Lines
$22.68 /

-0.47 (-2.03%)

ALK Alaska Air
$31.03 /

-0.79 (-2.48%)

AAL American Airlines
$9.70 /

-0.175 (-1.77%)

Periodicals
White House limits travel to U.S. from Brazil due to COVID, Reuters says » 18:14
05/25/20
05/25
18:14
05/25/20
18:14
SPY

SPDR S&P 500 ETF Trust

$295.47 /

+0.69 (+0.23%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The White House announced…

The White House announced that it is prohibiting foreigners from traveling to the United States if they had been in Brazil in the last two weeks, two days after the South American nation became the world No. 2 hot spot for coronavirus cases, according to Reuters. Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Sandler
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$295.47 /

+0.69 (+0.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Bayer makes progress in settlement talks over weedkiller, Reuters says » 18:10
05/25/20
05/25
18:10
05/25/20
18:10
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Bayer said on Monday it…

Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, Reuters' Ludwig Burger reports. The drugs and pesticides group is keen to draw a line under the legal dispute, which it inherited via its $63B takeover of Monsanto in 2018. In April, Bayer's management regained shareholder support for its handling of the litigation process. Reference Link

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

05/11/20 Wedbush
MyoKardia price target raised to $127 from $90 at Wedbush
04/22/20 Morgan Stanley
Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley
03/13/20 Goldman Sachs
Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs
03/11/20 Deutsche Bank
Deutsche Bank names Bayer as 'Catalyst Call' buy idea
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Periodicals
Intesa to give preliminary green light to state-backed loan for FCA,Reuters says » 18:06
05/25/20
05/25
18:06
05/25/20
18:06
FCAU

Fiat Chrysler

$8.12 /

+0.075 (+0.93%)

Italian bank Intesa…

Italian bank Intesa Sanpaolo is expected to give a preliminary green light at a board meeting on Tuesday to a state-backed $6.9B three-year loan for Fiat Chrysler, according to Reuters, citing a source familiar with the matter. Fiat Chrysler earlier this month said its Italian unit was working with Rome and Intesa Sanpaolo to obtain state guarantees on a loan facility designed to help the group's operations in the country and the whole Italian automotive industry, the publication notes. Reference Link

ShowHide Related Items >><<
FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

03/24/20 UBS
Tesla and BMW upgraded, Ford downgraded at UBS
03/11/20 Morgan Stanley
Morgan Stanley cuts estimates for GM, Ford and FCA on coronavirus 'demand shock'
12/18/19 Evercore ISI
Evercore ISI upgrades Fiat Chrysler to Outperform after Peugeot deal formalized
12/18/19 Evercore ISI
Fiat Chrysler upgraded to Outperform from In Line at Evercore ISI
FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

FCAU Fiat Chrysler
$8.12 /

+0.075 (+0.93%)

Periodicals
Daimler forges ahead with electric flagship sedan plans, Bloomberg says » 18:03
05/25/20
05/25
18:03
05/25/20
18:03
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

Daimler AG is pushing…

Daimler AG is pushing ahead with plans to produce an all-electric version of its flagship Mercedes S-Class sedan from next year even as it cuts back in other areas to weather a slump in demand across the industry, Bloomberg's Christoph Rauwald reports. The company's main Mercedes-Benz cars unit aims to make all of its factories CO2-neutral by the end of 2022, Chief Executive Officer Ola Kallenius said Monday in a webcast. Reference Link

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

05/04/20 RBC Capital
Daimler AG price target raised to EUR 42 from EUR 39 at RBC Capital
04/30/20 JPMorgan
Daimler AG price target raised to EUR 45 from EUR 29 at JPMorgan
03/30/20 Exane BNP Paribas
Daimler AG downgraded to Underperform from Neutral at Exane BNP Paribas
03/26/20 Kepler Cheuvreux
Daimler AG upgraded to Buy from Hold at Kepler Cheuvreux
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.